295 related articles for article (PubMed ID: 18852190)
1. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences.
Jean G; Bresson E; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Mar; 24(3):948-55. PubMed ID: 18852190
[TBL] [Abstract][Full Text] [Related]
2. Serological cardiovascular and mortality risk predictors in dialysis patients receiving sevelamer: a prospective study.
Brandenburg VM; Schlieper G; Heussen N; Holzmann S; Busch B; Evenepoel P; Vanholder R; Meijers B; Meert N; Fassbender WJ; Floege J; Jahnen-Dechent W; Ketteler M
Nephrol Dial Transplant; 2010 Aug; 25(8):2672-9. PubMed ID: 20172849
[TBL] [Abstract][Full Text] [Related]
3. High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients.
Jean G; Terrat JC; Vanel T; Hurot JM; Lorriaux C; Mayor B; Chazot C
Nephrol Dial Transplant; 2009 Sep; 24(9):2792-6. PubMed ID: 19395730
[TBL] [Abstract][Full Text] [Related]
4. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
[TBL] [Abstract][Full Text] [Related]
5. Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.
Nasrallah MM; El-Shehaby AR; Salem MM; Osman NA; El Sheikh E; Sharaf El Din UA
Nephrol Dial Transplant; 2010 Aug; 25(8):2679-85. PubMed ID: 20176609
[TBL] [Abstract][Full Text] [Related]
6. Lateral lumbar X-ray assessment of abdominal aortic calcification in Australian haemodialysis patients.
Toussaint ND; Pedagogos E; Lau KK; Heinze S; Becker GJ; Beavis J; Polkinghorne KR; Damasiewicz MJ; Kerr PG
Nephrology (Carlton); 2011 May; 16(4):389-95. PubMed ID: 21054667
[TBL] [Abstract][Full Text] [Related]
7. Vascular calcifications and renal osteodystrophy in chronic hemodialysis patients: what is the relationship between them?
Moldovan D; Moldovan I; Rusu C; Racasan S; Patiu IM; Brumboiu A; Bondor C; Parvu L; Kacso I; Orasan R; Gherman-Caprioara M
Int Urol Nephrol; 2011 Dec; 43(4):1179-86. PubMed ID: 20862543
[TBL] [Abstract][Full Text] [Related]
8. Ten-year experience with sevelamer and calcium salts as phosphate binders.
Raggi P; Vukicevic S; Moysés RM; Wesseling K; Spiegel DM
Clin J Am Soc Nephrol; 2010 Jan; 5 Suppl 1():S31-40. PubMed ID: 20089501
[TBL] [Abstract][Full Text] [Related]
9. Osteoprotegerin and progression of coronary and aortic calcifications in chronic kidney disease.
Mesquita M; Demulder A; Wolff F; Mélot C; Damry N; Dratwa M; Bergmann P
Transplant Proc; 2010 Nov; 42(9):3444-9. PubMed ID: 21094794
[TBL] [Abstract][Full Text] [Related]
10. Upper limb vascular calcification score as a predictor of mortality in diabetic hemodialysis patients.
Georgiadis GS; Argyriou C; Antoniou GA; Kantartzi K; Kriki P; Theodoridis M; Thodis E; Lazarides MK
J Vasc Surg; 2015 Jun; 61(6):1529-37. PubMed ID: 25724616
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with various arterial calcifications in haemodialysis patients.
Gelev S; Spasovski G; Trajkovski Z; Damjanovski G; Amitov V; Selim G; Dzekova P; Sikole A
Prilozi; 2008 Dec; 29(2):185-199. PubMed ID: 19259046
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of aortic calcification with lanthanum carbonate versus calcium-based phosphate binders in haemodialysis: A pilot randomized controlled trial.
Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
Nephrology (Carlton); 2011 Mar; 16(3):290-8. PubMed ID: 21342323
[TBL] [Abstract][Full Text] [Related]
13. Measurement of vascular calcification using CT fistulograms.
Toussaint ND; Lau KK; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2007 Feb; 22(2):484-90. PubMed ID: 17090606
[TBL] [Abstract][Full Text] [Related]
14. Increased levels of serum parathyroid hormone and fibroblast growth factor-23 are the main factors associated with the progression of vascular calcification in long-hour hemodialysis patients.
Jean G; Bresson E; Lorriaux C; Mayor B; Hurot JM; Deleaval P; Chazot C
Nephron Clin Pract; 2012; 120(3):c132-8. PubMed ID: 22584463
[TBL] [Abstract][Full Text] [Related]
15. Long-term sevelamer treatment lowers serum fibroblast growth factor 23 accompanied with increasing serum Klotho levels in chronic haemodialysis patients.
Lin HH; Liou HH; Wu MS; Lin CY; Huang CC
Nephrology (Carlton); 2014 Nov; 19(11):672-8. PubMed ID: 25113414
[TBL] [Abstract][Full Text] [Related]
16. Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease.
Toussaint ND; Lau KK; Strauss BJ; Polkinghorne KR; Kerr PG
Nephrol Dial Transplant; 2008 Feb; 23(2):586-93. PubMed ID: 17933842
[TBL] [Abstract][Full Text] [Related]
17. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
18. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients.
Adragão T; Pires A; Birne R; Curto JD; Lucas C; Gonçalves M; Negrão AP
Nephrol Dial Transplant; 2009 Mar; 24(3):997-1002. PubMed ID: 18952701
[TBL] [Abstract][Full Text] [Related]
19. Association between very low PTH levels and poor survival rates in haemodialysis patients: results from the French ARNOS cohort.
Jean G; Lataillade D; Genet L; Legrand E; Kuentz F; Moreau-Gaudry X; Fouque D;
Nephron Clin Pract; 2011; 118(2):c211-6. PubMed ID: 21178378
[TBL] [Abstract][Full Text] [Related]
20. Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
Ahmadi F; Shamekhi F; Lessan-Pezeshki M; Khatami MR
Saudi J Kidney Dis Transpl; 2012 Sep; 23(5):934-8. PubMed ID: 22982903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
